EUVIMEDEUVIMED entdecken
Crossref

Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab in the Treatment of Newly Diagnosed Postoperative Glioblastoma

C. Wang, H. Tu, C.B. Fan, Z. Tang, Q. Luo, Y. Luo

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e113

DOI: 10.1016/j.ijrobp.2026.06.899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von C. Wang und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, C., Tu, H., Fan, C., Tang, Z., Luo, Q., & Luo, Y. (2026). Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab in the Treatment of Newly Diagnosed Postoperative Glioblastoma. International Journal of Radiation Oncology*Biology*Physics, 126(1), e113. https://doi.org/10.1016/j.ijrobp.2026.06.899

Vancouver

Wang C, Tu H, Fan C, Tang Z, Luo Q, Luo Y. Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab in the Treatment of Newly Diagnosed Postoperative Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e113. doi:10.1016/j.ijrobp.2026.06.899

BibTeX
@article{Wang2026,
  author = {Wang, C. and Tu, H. and Fan, C.B. and Tang, Z. and Luo, Q. and Luo, Y.},
  title = {Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab in the Treatment of Newly Diagnosed Postoperative Glioblastoma},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e113},
  doi = {10.1016/j.ijrobp.2026.06.899}
}
Kostenlos starten →